首页> 外文期刊>International Journal of Ayurvedic Medicine >Management of Amavata (Rheumatoid arthritis) with herbo-mineral formulation -A clinical study
【24h】

Management of Amavata (Rheumatoid arthritis) with herbo-mineral formulation -A clinical study

机译:矿物质配方治疗Amavata(类风湿关节炎)-临床研究

获取原文
       

摘要

Rheumatoid Arthritis (R.A) is a chronic, progressive and disabling auto-immune disease that causes chronic inflammation of the joints. It makes life miserable and crippling due to unknown cause, claiming the maximum loss of human working capacity. The polyarticular joint disease has been described in Ayurveda has high resemblance with Rheumatoid arthritis in modern medicine. The disease draws attention for the consideration of research firstly due to the gravity of the problem and secondly due to lack of adverse free modern drugs for the treatment of R.A. Hence the present study has been taken up to see the efficacy of a combination of herbomineral drugs i.e Sunthi, Guggulu and Godanthi bhasma (1:2:1 ratio) on 71 cases of Amavata ( R.A). The study observations showed that the overall treatment response among the cases studied, 10 (15%) cases showed good response, 20 (30%) cases showed fair response, 33 (49%) cases showed mild response and 4 (06%) patients did not show any response and rest 4 cases were dropouts. There was a significant improvement in loss of appetite, anorexia, fever in amavata patients after treatment. Statistical analysis of the mean difference before and after treatment in relief on all the above symptoms except in sub cutaneous nodules and erythrocyte sedimentation rate (ESR), were found highly significant (P<0.0001). It was also observed a definite improvement and subjectively maximum patients had a feeling of well-being. No side effects were reported during and after the treatment.
机译:类风湿关节炎(R.A)是一种慢性,进行性和致残性自身免疫疾病,可引起关节的慢性炎症。由于未知原因,这使生活变得痛苦和残缺,这是对人类工作能力的最大损失。在现代医学中,阿育吠陀中已经描述了多关节关节疾病,其与类风湿关节炎高度相似。该疾病引起人们对研究考虑的关注,首先是由于问题的严重性,其次是由于缺乏治疗R.A.的不良免费现代药物。因此,本研究着眼于观察联合使用的矿物药,即Sunthi,Guggulu和Godanthi bhasma(比例为1:2:1)对71例Amavata(R.A)的疗效。研究观察结果表明,在所研究的病例中,总体治疗反应良好,其中10例(15%)表现出良好的反应,20例(30%)表现出中度反应,33例(49%)表现出轻度反应,4例(06%)没有反应,其余4例辍学。治疗后,avatata患者的食欲不振,厌食,发烧明显改善。除皮下结节和红细胞沉降率(ESR)外,上述所有症状缓解前和治疗后的平均差异的统计学分析均具有高度统计学意义(P <0.0001)。还观察到明显改善,主观上最大的患者有幸福感。在治疗期间和之后均未见副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号